Healthcare -
Biotechnology - NASDAQ - US
$ 12.69
1.2 %
$ 475 M
Market Cap
8.81
P/E
TRDA - CASH & EQUIVALENTS
Cash & Equivalents TRDA - Entrada Therapeutics, Inc.
67.6 M
LAST VALUE
-51.81%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR